Targeting Oncogenic Driver Mutations in Lung Cancer

Discover the cutting-edge insights in "Targeting Oncogenic Driver Mutations in Lung Cancer" by Matthew Lee, published by Cambridge University Press in 2023. This essential guide spans 75 pages and delves into the most clinically significant oncogenic drivers beyond EGFR, offering a comprehensive overview of their management and the latest advancements in treatment options.

Matthew Lee expertly navigates the complexities of resistance to targeted therapies and addresses the diagnostic challenges associated with each oncogenic driver. This Element not only highlights current practices but also explores the future direction of non-small cell lung cancer (NSCLC) management, making it a vital resource for healthcare professionals and researchers alike. Enhance your understanding of lung cancer treatment with this informative and engaging publication.